In SCID mice model bearing human breast cancer cell line xenografts, MUC1-FA-[18F] SFB hybrid peptide demonstrated excellent tumor uptake and favorable pharmacokinetics over MUC1-[18F] SFB peptide conjugate. Here, MUC1 is linked to breast carcinoma.